Literature DB >> 2754303

Public cholesterol screening: motivation for participation, follow-up outcome, self-knowledge, and coronary heart disease risk factor intervention.

H Stockbridge1, R I Hardy, C J Glueck.   

Abstract

We used a mailed questionnaire and telephone interviews with 1717 shopping center screenees whose total serum cholesterol was greater than 200 mg/dl. Our specific aim was to assess the subjects' motivations for participation in cholesterol screening, their follow-up outcome, their self-knowledge, and any coronary heart disease risk factor intervention. Of 1717 questionnaires mailed, 507 (30%) were returned; 64 of 100 subjects randomly selected for telephone interview could be contacted, and 61 were interviewed. Responses to the questionnaire and telephone interview were congruent, indicating little self-selection response bias. Before the cholesterol screening, 50% and 67% of questionnaire and telephone interview subjects knew their cholesterol levels. The nine most commonly cited reasons for cholesterol screening participation were: a desire to "watch" health (72%), convenience (70%), low cost (64%), to recheck previously measured total cholesterol (54%), publicity (34%), curiosity (30%), a relative with premature coronary heart disease (27%), the subjects' obesity (26%), and a relative's high cholesterol level (25%). As a result of cholesterol screening, 65% and 63% of questionnaire and telephone interview subjects, respectively, followed up with their doctors; 67% and 56%, respectively, had total cholesterol remeasured, but 17% and 18%, respectively, were told to "do nothing." At their doctors' follow-up, 74% and 51% of questionnaire and telephone interview respondents, respectively, began a low-saturated fat, low-cholesterol diet; 10% and 15% started taking a cholesterol-lowering drug. As a result of cholesterol screening, 76% and 85% of questionnaire and telephone interview subjects, respectively, changed their diets; 78% and 84% lowered their dietary cholesterol intakes, 62% and 74% increased their fiber intakes, 49% and 57% tried to lose weight, and 44% and 43% increased their exercise. Of questionnaire subjects, 94% thought that by lowering cholesterol, coronary heart disease risk could be reduced; 95% had become more aware of cholesterol in the last 5 years. Of telephone interview subjects, 91% concluded that cholesterol screening had motivated them to reduce cholesterol levels. Public cholesterol screening is convenient, inexpensive, facilitates self-knowledge about cholesterol, stimulates follow-up, and motivates physician and subject-guided dietary changes to reduce cholesterol levels and coronary heart disease risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2754303

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Anti-hyperglycemic and anti-hyperlipidemic potential of a polyherbal preparation "Diabegon" in metabolic syndrome subject with type 2 diabetes.

Authors:  Dhananjay Yadav; Arvind Tiwari; Meerambika Mishra; Senthil S Subramanian; Usha Singh Baghel; Sunil Mahajan; P S Bisen; G B K S Prasad
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-01-28

2.  β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.

Authors:  Ederlan S Ferreira; Maraiza A Silva; Aureluce Demonte; Valdir A Neves
Journal:  Lipids Health Dis       Date:  2012-01-13       Impact factor: 3.876

3.  Hypocholesterolaemic effect of rat-administered oral doses of the isolated 7S globulins from cowpeas and adzuki beans.

Authors:  Ederlan S Ferreira; Ana Lucia S Amaral; Aureluce Demonte; Cleslei F Zanelli; Jessica Capraro; Marcello Duranti; Valdir A Neves
Journal:  J Nutr Sci       Date:  2015-02-16

4.  Prevalence of dyslipidemia and hypertension in Indian type 2 diabetic patients with metabolic syndrome and its clinical significance.

Authors:  Dhananjay Yadav; Meerambika Mishra; Arvind Tiwari; Prakash Singh Bisen; Hari Mohan Goswamy; G B K S Prasad
Journal:  Osong Public Health Res Perspect       Date:  2014-05-09

5.  Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia.

Authors:  Rabia Shabir Ahmad; Masood Sadiq Butt; M Tauseef Sultan; Zarina Mushtaq; Shakeel Ahmad; Saikat Dewanjee; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  J Transl Med       Date:  2015-03-04       Impact factor: 5.531

6.  Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.

Authors:  Dhananjay Yadav; Sunil Mahajan; Senthil Kumar Subramanian; Prakash Singh Bisen; Choon Hee Chung; G B K S Prasad
Journal:  Glob J Health Sci       Date:  2013-09-17

7.  Antihyperlipidemic efficacy of aqueous extract of Stevia rebaudiana Bertoni in albino rats.

Authors:  Uswa Ahmad; Rabia Shabir Ahmad; Muhammad Sajid Arshad; Zarina Mushtaq; Syed Makhdoom Hussain; Aneela Hameed
Journal:  Lipids Health Dis       Date:  2018-07-27       Impact factor: 3.876

8.  Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.

Authors:  Antonio Palazón-Bru; Vicente F Gil-Guillén; Domingo Orozco-Beltrán; Vicente Pallarés-Carratalá; Francisco Valls-Roca; Carlos Sanchís-Domenech; José M Martín-Moreno; Josep Redón; Jorge Navarro-Pérez; Antonio Fernández-Giménez; Ana M Pérez-Navarro; José L Trillo; Ruth Usó; Elías Ruiz
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

9.  Nigella sativa Fixed and Essential Oil Supplementation Modulates Hyperglycemia and Allied Complications in Streptozotocin-Induced Diabetes Mellitus.

Authors:  Muhammad Tauseef Sultan; Masood Sadiq Butt; Roselina Karim; M Zia-Ul-Haq; Rizwana Batool; Shakeel Ahmad; Luigi Aliberti; Vincenzo De Feo
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

10.  Phytochemical composition, antilipidemic and antihypercholestrolemic perspectives of Bael leaf extracts.

Authors:  Nosheen Asghar; Zarina Mushtaq; Muhammad Umair Arshad; Muhammad Imran; Rabia Shabir Ahmad; Syed Makhdoom Hussain
Journal:  Lipids Health Dis       Date:  2018-04-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.